'con

Gale Lab HomeGale Lab ResearchGale Lab FundingGale Lab PublicationsGale Lab PeopleOpportunities in the Gale LabGale Lab EducationConferencesGale Lab Contact
 

 
Center for the Study of Immune Mechanisms of Flavivirus Control | Hepatitis C Cooperative Research Center
PNWRCE | Innate Immune Adjuvant Discovery | Systems Immunogenetics

The Center for the Study of Innate Immunity and Hepatitis C Infection, is a component of the Hepatitis C Cooperative Research Centers funded by the NIH. The center is comprised of three translational research projects. The shared goal of these sites is to develop understanding of the virus/host interactions of hepatitis C virus (HCV) that regulate innate immunity, therapy, and the outcome of infection. These efforts are providing novel insights to guide the design of improved therapeutic strategies and vaccine approaches aimed at modulating HCV infection and immunity.
National Institutes of Health

Our studies are focused on:
Defining the viral and host genetic determinants that confer pathogen recognition of HCV, regulate hepatic innate immune triggering, and mediate effector and evasion responses during infection.

Defining the HCV/host interactions that drive hepatic IFN production and response between hepatocytes and liver dendritic cells to control HCV infection.

Project 1:
Dr. Michael Gale Jr.
Pathogen signaling and innate immune control by HCV


Project 2:
Dr. Francis Chisari

Mechanisms of interferon induction by HCV


Project 3:
Dr. Daryl Lau

Interferon-induced hepatic MicroRNA in HCV

UW School of Medicine

 
Scripps Research Institute
Beth Israel Deaconess Medical Center

 

Administrative Core
Dr. Michael Gale Jr, Program Director
Melissa Petersen, Center Administrator

Clinical Core
Dr. Daryl Lau, Patient Care and Biological Specimens

Hepatitis C Information:

CDC Expanded Hepatitis C Testing Recommendations

MedlinePlus: Hepatitis C
  NIAID: Hepatitis C
 
 
HCV Advocate
 

UNIVERSITY OF WASHINGTON